 This meta-analysis was conducted to investigate the diagnostic performance of P16 Two reviewers independently searched the Web of Science , PubMed , Cochrane , Embase , China National Knowledge Infrastructure , and Chinese Biomedical Literature databases. Publications relevant to P16 Twenty-six publications with 1768 lung cancer cases and 1323 controls were included. The pooled sensitivity , specificity , positive and negative likelihood ratios , and diagnostic odds ratio were 0.46 ( 95 % confidence interval ( CI) 0.43-0.48) , 0.90 ( 95 % CI 0.88-0.91) , 6.33 ( 95 % CI 3.89-10.30) , 0.57 ( 95 % CI 0.50-0.65) and 10.72 ( 95 % CI 6.94-16.56) , respectively , for P16 P16